Trials / Completed
CompletedNCT01911039
Phase 1 Infused Donor T Regulatory Cells in Steroid Dependent/Refractory Chronic GVHD
A Phase 1 Safety and Tolerability Study of Infused Donor T Regulatory Cells in Steroid Dependent/Refractory Chronic Graft Versus Host Disease
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- Laura Johnston · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Chronic graft versus host disease (cGVHD) is a common complication of bone marrow or hematopoietic cell transplant from another person (allogeneic transplant). This study will determine if subjects with steroid dependent/refractory cGVHD can tolerate infusion of donor regulatory T cells and whether their cGVHD responds to the infusion.
Detailed description
PRIMARY OBJECTIVES: Determine the safety and tolerability of donor T regulatory (Treg) cell infusions in subjects with steroid dependent/refractory chronic graft versus host disease. SECONDARY OBJECTIVES: 1. Determine the quantitative blood Treg cell changes following the cell infusions 2. Determine clinical efficacy of donor Treg cells as failure-free survival (FFS) defined by the absence of a new immunosuppressive therapy added, non-relapse mortality, and recurrent malignancy at Day 180 after the first Treg infusion 3. In addition to FFS, the study will measure the change in: 1. cGVHD symptom burden measured by the Lee cGVHD Symptom Scale by increase in \>7 points 2. NIH organ-specific cGVHD scale 3. The reduction in daily corticosteroid requirement of prednisone to \<=0.25 mg/kg-day at Day 180 after the first Treg infusion
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Regulatory T Cells |
Timeline
- Start date
- 2013-07-01
- Primary completion
- 2017-12-31
- Completion
- 2018-07-31
- First posted
- 2013-07-30
- Last updated
- 2021-09-27
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT01911039. Inclusion in this directory is not an endorsement.